BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18557791)

  • 1. FADD and the NF-kappaB family member Bcl-3 regulate complementary pathways to control T-cell survival and proliferation.
    Rangelova S; Kirschnek S; Strasser A; Häcker G
    Immunology; 2008 Dec; 125(4):549-57. PubMed ID: 18557791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of a B-cell-restricted isoform of CD45 is associated with maturity in rat serosal and connective-tissue mast cells.
    Yu C; Moghaddami M; Mayrhofer G
    Immunology; 2008 Dec; 125(4):558-69. PubMed ID: 19137648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a dominant interfering mutant of FADD on signal transduction in activated T cells.
    Newton K; Kurts C; Harris AW; Strasser A
    Curr Biol; 2001 Feb; 11(4):273-6. PubMed ID: 11250157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant Negative FADD/MORT1 Inhibits the Development of Intestinal Intraepithelial Lymphocytes With a Marked Defect on CD8αα+TCRγδ+ T Cells.
    Zhang X; Huo L; Song L; Hu Z; Wang X; Han Y; Wang Y; Xu P; Zhang J; Hua ZC
    Front Immunol; 2018; 9():2038. PubMed ID: 30250469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo.
    Jones RG; Parsons M; Bonnard M; Chan VS; Yeh WC; Woodgett JR; Ohashi PS
    J Exp Med; 2000 May; 191(10):1721-34. PubMed ID: 10811865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor.
    Newton K; Harris AW; Strasser A
    EMBO J; 2000 Mar; 19(5):931-41. PubMed ID: 10698935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic overexpression of a dominant negative mutant of FADD that, although counterselected during tumor progression, cooperates in L-myc-induced tumorigenesis.
    Hueber AO; Bösser S; Zörnig M
    Int J Cancer; 2004 Nov; 112(3):536-40. PubMed ID: 15382083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1.
    Zhang J; Cado D; Chen A; Kabra NH; Winoto A
    Nature; 1998 Mar; 392(6673):296-300. PubMed ID: 9521326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The c-FLIPL cleavage product p43FLIP promotes activation of extracellular signal-regulated kinase (ERK), nuclear factor κB (NF-κB), and caspase-8 and T cell survival.
    Koenig A; Buskiewicz IA; Fortner KA; Russell JQ; Asaoka T; He YW; Hakem R; Eriksson JE; Budd RC
    J Biol Chem; 2014 Jan; 289(2):1183-91. PubMed ID: 24275659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB.
    Tsatsanis C; Patriotis C; Tsichlis PN
    Oncogene; 1998 Nov; 17(20):2609-18. PubMed ID: 9840924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dominant negative Fas-associated death domain protein mutant inhibits proliferation and leads to impaired calcium mobilization in both T-cells and fibroblasts.
    Hueber AO; Zörnig M; Bernard AM; Chautan M; Evan G
    J Biol Chem; 2000 Apr; 275(14):10453-62. PubMed ID: 10744735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fas-associated death domain (FADD) is a negative regulator of T-cell receptor-mediated necroptosis.
    Osborn SL; Diehl G; Han SJ; Xue L; Kurd N; Hsieh K; Cado D; Robey EA; Winoto A
    Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13034-9. PubMed ID: 20615958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic mice.
    Zörnig M; Hueber AO; Evan G
    Curr Biol; 1998 Apr; 8(8):467-70. PubMed ID: 9550704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FADD regulates thymocyte development at the β-selection checkpoint by modulating Notch signaling.
    Zhang X; Dong X; Wang H; Li J; Yang B; Zhang J; Hua ZC
    Cell Death Dis; 2014 Jun; 5(6):e1273. PubMed ID: 24901044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced basal AP-1 activity and de-regulation of numerous genes in T cells transgenic for a dominant interfering mutant of FADD/MORT1.
    Chaneva S; Schneider G; Siegmund D; Wajant H; Mages J; Häcker G
    Eur J Immunol; 2004 Nov; 34(11):3006-15. PubMed ID: 15376191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional Fas-associated death domain protein (FADD): GFP knockout mice reveal FADD is dispensable in thymic development but essential in peripheral T cell homeostasis.
    Zhang Y; Rosenberg S; Wang H; Imtiyaz HZ; Hou YJ; Zhang J
    J Immunol; 2005 Sep; 175(5):3033-44. PubMed ID: 16116191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular FLICE-inhibitory protein is required for T cell survival and cycling.
    Chau H; Wong V; Chen NJ; Huang HL; Lin WJ; Mirtsos C; Elford AR; Bonnard M; Wakeham A; You-Ten AI; Lemmers B; Salmena L; Pellegrini M; Hakem R; Mak TW; Ohashi P; Yeh WC
    J Exp Med; 2005 Aug; 202(3):405-13. PubMed ID: 16043518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Rho-family GTP exchange factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-kappaB pathways.
    Costello PS; Walters AE; Mee PJ; Turner M; Reynolds LF; Prisco A; Sarner N; Zamoyska R; Tybulewicz VL
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3035-40. PubMed ID: 10077632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting edge: FADD is not required for antigen receptor-mediated NF-kappaB activation.
    Arechiga AF; Bell BD; Solomon JC; Chu IH; Dubois CL; Hall BE; George TC; Coder DM; Walsh CM
    J Immunol; 2005 Dec; 175(12):7800-4. PubMed ID: 16339514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominant negative FADD dissipates the proapoptotic signalosome of the unfolded protein response in diabetic embryopathy.
    Wang F; Weng H; Quon MJ; Yu J; Wang JY; Hueber AO; Yang P
    Am J Physiol Endocrinol Metab; 2015 Nov; 309(10):E861-73. PubMed ID: 26419589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.